Drug: Avelumab (Bavencio, EMD Serono)
Status: Approved for the treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease progressed during or after platinum-containing chemotherapy, or within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy
Significant Information:
- Based on data from an open-label, single-arm, multicenter study of 242 patients
- All patients were given premedication with an antihistamine and acetaminophen before receiving